HOYA Corporation

TSE:7741 Stock Report

Market Cap: JP¥6.8t

HOYA Valuation

Is 7741 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7741 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 7741 (¥19530) is trading below our estimate of fair value (¥21410.55)

Significantly Below Fair Value: 7741 is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7741?

Key metric: As 7741 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 7741. This is calculated by dividing 7741's market cap by their current earnings.
What is 7741's PE Ratio?
PE Ratio34.7x
EarningsJP¥195.84b
Market CapJP¥6.79t

Price to Earnings Ratio vs Peers

How does 7741's PE Ratio compare to its peers?

The above table shows the PE ratio for 7741 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average68.4x
7747 Asahi Intecc
41.6x12.1%JP¥686.4b
8086 Nipro
181.9x25.4%JP¥237.7b
7730 Mani
27.9x9.2%JP¥175.1b
7780 Menicon
22.5x18.3%JP¥108.8b
7741 HOYA
34.7x11.4%JP¥6.8t

Price-To-Earnings vs Peers: 7741 is good value based on its Price-To-Earnings Ratio (34.7x) compared to the peer average (68.4x).

Price to Earnings Ratio vs Industry

How does 7741's PE Ratio compare vs other companies in the JP Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
7741 34.7xIndustry Avg. 16.0xNo. of Companies7PE01224364860+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 7741 is expensive based on its Price-To-Earnings Ratio (34.7x) compared to the JP Medical Equipment industry average (16x).

Price to Earnings Ratio vs Fair Ratio

What is 7741's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7741 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio34.7x
Fair PE Ratio33x

Price-To-Earnings vs Fair Ratio: 7741 is expensive based on its Price-To-Earnings Ratio (34.7x) compared to the estimated Fair Price-To-Earnings Ratio (33x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 7741 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥19,530.00
JP¥22,996.88
+17.8%
8.5%JP¥26,000.00JP¥19,200.00n/a16
Dec ’25JP¥19,260.00
JP¥22,865.63
+18.7%
8.4%JP¥26,000.00JP¥19,200.00n/a16
Nov ’25JP¥20,485.00
JP¥22,600.00
+10.3%
8.4%JP¥26,000.00JP¥19,200.00n/a14
Oct ’25JP¥20,055.00
JP¥22,244.23
+10.9%
8.3%JP¥26,000.00JP¥19,200.00n/a13
Sep ’25JP¥20,595.00
JP¥22,155.36
+7.6%
8.5%JP¥26,000.00JP¥19,200.00n/a14
Aug ’25JP¥18,680.00
JP¥21,861.54
+17.0%
7.6%JP¥24,500.00JP¥19,200.00n/a13
Jul ’25JP¥18,570.00
JP¥21,553.85
+16.1%
6.5%JP¥24,000.00JP¥19,000.00n/a13
Jun ’25JP¥19,060.00
JP¥21,169.23
+11.1%
6.0%JP¥23,000.00JP¥19,000.00n/a13
May ’25JP¥18,435.00
JP¥20,796.15
+12.8%
6.6%JP¥23,000.00JP¥18,500.00n/a13
Apr ’25JP¥18,830.00
JP¥20,454.17
+8.6%
6.1%JP¥22,500.00JP¥18,500.00n/a12
Mar ’25JP¥19,935.00
JP¥20,496.15
+2.8%
6.2%JP¥22,500.00JP¥18,500.00n/a13
Feb ’25JP¥18,550.00
JP¥19,457.69
+4.9%
10.1%JP¥22,000.00JP¥15,050.00n/a13
Jan ’25JP¥17,625.00
JP¥18,204.55
+3.3%
12.7%JP¥22,000.00JP¥14,400.00n/a11
Dec ’24JP¥16,465.00
JP¥17,662.50
+7.3%
10.7%JP¥21,000.00JP¥14,400.00JP¥19,260.0012
Nov ’24JP¥15,120.00
JP¥17,745.83
+17.4%
11.1%JP¥21,000.00JP¥14,400.00JP¥20,485.0012
Oct ’24JP¥15,325.00
JP¥18,154.55
+18.5%
9.3%JP¥21,000.00JP¥16,000.00JP¥20,055.0011
Sep ’24JP¥16,235.00
JP¥18,010.00
+10.9%
9.6%JP¥21,000.00JP¥16,000.00JP¥20,595.0010
Aug ’24JP¥16,850.00
JP¥17,636.36
+4.7%
11.4%JP¥21,000.00JP¥14,000.00JP¥18,680.0011
Jul ’24JP¥17,075.00
JP¥17,425.00
+2.0%
12.9%JP¥21,000.00JP¥14,000.00JP¥18,570.0012
Jun ’24JP¥17,845.00
JP¥16,769.23
-6.0%
9.5%JP¥20,000.00JP¥14,000.00JP¥19,060.0013
May ’24JP¥14,500.00
JP¥16,138.46
+11.3%
6.3%JP¥18,000.00JP¥14,000.00JP¥18,435.0013
Apr ’24JP¥14,560.00
JP¥16,323.08
+12.1%
7.2%JP¥18,000.00JP¥14,000.00JP¥18,830.0013
Mar ’24JP¥13,225.00
JP¥16,323.08
+23.4%
7.2%JP¥18,000.00JP¥14,000.00JP¥19,935.0013
Feb ’24JP¥13,785.00
JP¥16,650.00
+20.8%
9.5%JP¥20,000.00JP¥14,000.00JP¥18,550.0014
Jan ’24JP¥12,705.00
JP¥16,784.62
+32.1%
9.0%JP¥20,000.00JP¥14,500.00JP¥17,625.0013
Dec ’23JP¥14,270.00
JP¥17,023.08
+19.3%
11.1%JP¥21,100.00JP¥14,500.00JP¥16,465.0013

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 06:23
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HOYA Corporation is covered by 33 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Warren LauAletheia Analyst Network Limited
Masahiro NakanomyoBarclays
Kunihiko KannoBNP Paribas Securities (Asia)